Patents
Sitemap › A01 - Agriculture; Forestry; Animal husbandry; Hunting; Trapping; Fishing › A01K - Animal husbandry; Care of birds, fishes, insects; Fishing; Rearing or breeding animals, not otherwise provided for; New breeds of animals › A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals
Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2003
12/17/2003CN2591966Y Apparatus for making silkworm produce silk and cocooning on a surface
12/17/2003CN2591965Y Dusting machine for silkworm
12/17/2003CN1461587A Natural ecology regression type method for raising health lvestock and structure therefor
12/17/2003CN1131240C Chromosome 21 gene marker, compositions and methods using same
12/16/2003US6664441 Compound assay
12/16/2003US6664107 Insertion of exogenous DNA into genome of mammals producing transgenic mammals with decreased/suppressed endogenous gene expression and/or with expression of a novel gene(s); use in screening drugs for immunostimulatory effects
12/16/2003US6664075 Polypeptide binds to patched protein; genetic engineering
12/16/2003US6664068 Antibodies, antiapoptotic agents
12/11/2003WO2003102230A1 Pthrp-based prediction and diagnosis of bone disease
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102199A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
12/11/2003WO2003102176A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
12/11/2003WO2003102026A1 Caudal protein recognizing e2f promoter, transformants of overexpressing caudal, and use thereof
12/11/2003WO2003101497A1 Knockout mice and their use
12/11/2003WO2003101189A1 Inducible eukaryotic expression system
12/11/2003WO2003101188A1 Chronic stress-related disease model animal and method of constructing the same
12/11/2003WO2003101187A1 Animal model for toxicology and dose prediction
12/11/2003WO2003064463A3 Pluripotency determining factors and uses thereof
12/11/2003WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods
12/11/2003WO2003025220A3 Fusion proteins useful for detecting analytes
12/11/2003WO2003000727A3 Atopy
12/11/2003WO2002089567A3 Sca2 knockout animal and methods of use
12/11/2003WO2002088305A3 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
12/11/2003WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/11/2003US20030229913 Transgenic fish embryo with reduced endothelial growth factor (FLT1) expression for treating tumorous disorders; antisense therapy; angiogenesis inhibitors
12/11/2003US20030229912 Non-human transgenic mammals and their use as a disease model
12/11/2003US20030229911 Compositions and methods for wound healing
12/11/2003US20030229910 Preparing transgenic cattle which are resistant to bovine spongioform encephalopathy; homologous recombination; animal husbandry; veterinary medicine
12/11/2003US20030229907 Transgenic non-human mammals with progressive neurologic disease
12/11/2003US20030229906 Preventing kidney cell dedifferentiation and viral nephropathy using peptide inhibitors; enzyme inhibitors; viricides; mimetics
12/11/2003US20030229905 Generation of xenogeneic antibodies
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229903 Novel system for the evaluation of the activity and/or specificity of a viral component
12/11/2003US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228581 Comparing the nucleotide sequence encoding the AIF protein from a human biopsy to a wild-type
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003CA2490051A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003CA2487928A1 Pthrp-based prediction and diagnosis of bone disease
12/11/2003CA2487765A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2486548A1 Animal model for toxicology and dose prediction
12/11/2003CA2485939A1 Inducible eukaryotic expression system
12/11/2003CA2480326A1 Knockout mice and their use
12/10/2003EP1368481A2 Characterization of the i-spoml endonuclease from fission yeast
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1367886A2 Scce modified transgenic mammals and their use as models of human disease
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen
12/10/2003CN2590371Y Cricket thermostat rearing box
12/10/2003CN2590370Y Automatic separator for sulphur and pupa
12/10/2003CN1461343A 多核苷酸 Polynucleotide
12/10/2003CN1461339A Transferring nucleus of long-period cultured female or male cell including one changed by artificial induction gene into denucleated receptor cell
12/09/2003US6660905 Mice comprising engrafted functional human hepatocytes
12/09/2003US6660904 Identifying a compound which modulates effects of HIV-1 infection in a cell
12/09/2003US6660474 Identifying individuals predisposed to essential hypertension and related conditions such as salt sensitivity by detecting the presence of polymorphic or mutant forms of the GRK4 gene, or its expression product.
12/06/2003CA2431338A1 Method for preventing decrease of breast milk amount in mammals
12/04/2003WO2003100074A2 Animal genotyping method
12/04/2003WO2003100070A2 The frog prince, a transposon vector for gene transfer in vertebrates
12/04/2003WO2003100028A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
12/04/2003WO2003099995A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099003A1 Adiponectin-knoucout nonhuman animal
12/04/2003WO2003099002A1 Cathepsin-associaged genetically modified nonhuman mammal
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003087322A3 Production of haematophagous organisms and parasites suitable for vaccine production
12/04/2003WO2003075838A3 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/04/2003WO2003064627A3 Chimeric bird from embryonic stem cells
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003048338A3 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
12/04/2003WO2003046134A3 Expression of polypeptides in rod outer segment membranes
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003026404A3 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003026398A3 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003017918A3 A method of inducing the formation of neurofibrillary tangles in transgenic animals
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003002746A3 Perv screening method and use thereof
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002069840A3 Nucleic acids for transforming fish cells and methods for their use
12/04/2003WO2002068635A3 Methods of inhibiting expression of a target gene in mammalian cells
12/04/2003US20030226159 Preparation of transgenic animal model for monitoring tumor development and treatments using stem cells
12/04/2003US20030226158 Cds1 knockout cells and mice, and their utilization
12/04/2003US20030226157 Transgenic rodent which functions as evaluative tool when monitoring the effects of viricides on DNA viruses that induce hyperproliferative lesions in oral and urogenital epithelial tissues; immunotherapy
12/04/2003US20030226156 Obtaining and identifying drosophila neurodegeneration mutant which demonstrates temperature-sensitive and bang-sensitive paralysis phenotypes; neuroprotectants
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030226154 Pathophysiology associated with a single gene (MASS 1) mutation underlying the robust audiogenic seizure phenotype in frings mice
12/04/2003US20030224521 Using artificial bacterial chromosome and homologous recombination as tools for stable transfer of genetic material into cells; gene replacement; transgenic animal models
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224350 Elimination of endogenous porcine retrovirus
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223993 Novel steroid-activated nuclear receptors and uses therefor
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003CA2497091A1 Adiponectin-knoucout nonhuman animal
12/04/2003CA2487322A1 Animal genotyping method
12/04/2003CA2483201A1 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 341